Eastern Bank reduced its position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 58.1% in the second quarter, Holdings Channel reports. Eastern Bank’s holdings in Novo Nordisk A/S were worth $5,877,000 at the end of the most recent reporting period. Price T Rowe Associates Inc. MD increased its holdings in shares of Novo Nordisk A/S by 99.7% in the 4th quarter. Get Novo Nordisk A/S alerts:Novo Nordisk A/S News SummaryHere are the key news stories impacting Novo Nordisk A/S this week:Novo Nordisk A/S Stock Up 0.1%Shares of NVO opened at $47.12 on Tuesday. Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.